Edward G. Brooks

Edward G. Brooks

Auto-generated profile, based on publicly available information

Edward G. Brooks

Joe R. and Teresa Lozano Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2001 in Annals of Allergy, Asthma & Immunology
Verified
Journal Article
Closed access
TMTerumi Midoro-Horiuti
Terumi Midoro-Horiuti
EBEdward G. Brooks
Edward G. Brooks
RGRandall M. Goldblum
Randall M. Goldblum

1 February 2018 in American Journal of Respiratory Cell and Molecular Biology
Verified
Journal Article
Closed access
DMDiego Maselli
Diego Maselli
JMJorge L. Medina
Jorge L. Medina
EBEdward G. Brooks
Edward G. Brooks
JCJacqueline J. Coalson
Jacqueline J. Coalson
TKThirumalai R. Kannan
Thirumalai R. Kannan
JPJay Peters
Jay Peters
Mycoplasma pneumoniae infection has been linked to poor asthma outcomes. M. pneumoniae produces an ADP-ribosylating and vacuolating toxin called community-acquired respiratory distress syndrome (CARDS) toxin that has a major role in inflammation and airway dysfunction. The objective was to evaluate the immunopathological effects in primates exposed to M. pneumoniae or CARDS toxin. A total of 13 baboons were exposed to M. pneumoniae or CARDS toxin. At Days 7 and 14, BAL fluid was collected and analyzed for cell count, percent of each type of cell, CARDS toxin by PCR, CARDS toxin by antigen capture, eosinophilic cationic protein, and cytokine profiles. Serum IgM, IgG, and IgE responses to CARDS toxin were measured. All animals had a necropsy for analysis of the histopathological changes on lungs. No animal developed signs of infection. The serological responses to CARDS toxin were variable. At Day 14, four of seven animals exposed to M. pneumoniae and all four animals exposed to CARDS toxin developed histological “asthma-like” changes. T cell intracellular cytokine analysis revealed an increasing ratio of IL-4/IFN-γ over time. Both M. pneumoniae and CARDS toxin exposure resulted in similar histopathological pulmonary changes, suggesting that CARDS toxin plays a major role in the inflammatory response.

2 February 2016 in Seminars in Immunopathology
Verified
Journal Article
Closed access
PDF file
AAArmen N. Akopian
Armen N. Akopian
EFE. Robert Fanick
E. Robert Fanick
EBEdward G. Brooks
Edward G. Brooks

10 October 2012 in Environmental Toxicology
Verified
Journal Article
Closed access
PDF file
DHDaniel J. Hochman
Daniel J. Hochman
CCChristopher R. Collaco
Christopher R. Collaco
EBEdward G. Brooks
Edward G. Brooks

8 February 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
LSLi She
Li She
GBGema D. Barrera
Gema D. Barrera
LYLiping Yan
Liping Yan
HAHamad H. Alanazi
Hamad H. Alanazi
EBEdward G. Brooks
Edward G. Brooks
XLXiaodong Li
Xiaodong Li
2′3′-cGAMP is known as a nonclassical second messenger and small immune modulator that possesses potent antitumor and antiviral activities via inducing the stimulator of IFN genes–mediated (STING-mediated) signaling pathway. However, its function in regulating type 2 immune responses remains unknown. Therefore, we sought to determine a role of STING activation by 2′3′-cGAMP in type 2 inflammatory reactions in multiple mouse models of eosinophilic asthma. We discovered that 2′3′-cGAMP administration strongly attenuated type 2 lung immunopathology and airway hyperreactivity induced by IL-33 and a fungal allergen, Aspergillus flavus . Mechanistically, upon the respiratory delivery, 2′3′-cGAMP was mainly internalized by alveolar macrophages, in which it activated the STING/IFN regulatory factor 3/type I IFN signaling axis to induce the production of inhibitory factors containing IFN-α, which blocked the IL-33–mediated activation of group 2 innate lymphoid (ILC2) cells in vivo. We further demonstrated that 2′3′-cGAMP directly suppressed the proliferation and function of both human and mouse ILC2 cells in vitro. Taken together, our findings suggest that STING activation by 2′3′-cGAMP in alveolar macrophages and ILC2 cells can negatively regulate type 2 immune responses, implying that the respiratory delivery of 2′3′-cGAMP might be further developed as an alternative strategy for treating type 2 immunopathologic diseases such as eosinophilic asthma.

1 August 2018 in Clinical Reviews in Allergy & Immunology
Verified
Journal Article
Closed access
PDF file
JGJesus R. Guajardo
Jesus R. Guajardo
MZMelissa A. Zegarra-Bustamante
Melissa A. Zegarra-Bustamante
EBEdward G. Brooks
Edward G. Brooks